Biological and clinical roles of adrenomedullin in circulation control and cardiovascular diseases

被引:81
作者
Eto, T [1 ]
Kitamura, K [1 ]
Kato, J [1 ]
机构
[1] Miyazaki Med Coll, Dept Internal Med 1, Miyazaki 8891692, Japan
关键词
adrenomedullin; anti-hypertensive substance; circulation control; vasoactive peptide;
D O I
10.1046/j.1440-1681.1999.03047.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
1. Adrenomedullin(AM) is found ubiquitously in tissues and organs, especially in cardiovascular tissues and in the kidney, lung and endocrine glands. It has multifunctional biological properties, of which, its effects on the control of circulation and body fluid volume regulation seem to be the most outstanding and characteristic. 2. Acute administration of a high dose of AR I induces a vasodilator depressor response, cardiac inotropic effects, diuresis and suppression of aldosterone secretion in experimental animals. 3. Long-term continuous administration of a very low dose of AM causes vasodilation in sheep (0.5 mu g/kg per h) and hypotension in rats (0.8 mu g/kg per h), 4. The plasma concentration of AM increases under pathological conditions such as congestive heart failure, myocardial infarction and hypertensive and renal diseases. Under these disease conditions, AM may be produced in vascular endothelial and smooth muscle cells and in cardiac myocytes in response to volume expansion, hypertension and activated humoral factors, such as catecholanline and the renin-angiotensin system. 5. Increased API I in the circulating blood and cardiovascular tissues mag counteract pathological deviation in the system that controls circulation and body fluid volume, acting against cardiovascular damage and disease. 6. Because of these beneficial properties in the cardiovascular system, AM and its pharmaceutical ligands should prove useful in the treatment of cardiovascular diseases.
引用
收藏
页码:371 / 380
页数:10
相关论文
共 88 条
[51]   ATTENUATION OF ADRENOMEDULLIN-INDUCED RENAL VASODILATATION BY N-G-NITRO-L-ARGININE BUT NOT GLIBENCLAMIDE [J].
MIURA, K ;
EBARA, T ;
OKUMURA, M ;
MATSUURA, T ;
KIM, S ;
YUKIMURA, T ;
IWAO, H .
BRITISH JOURNAL OF PHARMACOLOGY, 1995, 115 (06) :917-924
[52]   Expression of adrenomedullin and its receptor during embryogenesis suggests autocrine or paracrine modes of action [J].
Montuenga, LM ;
Martinez, A ;
Miller, MJ ;
Unsworth, EJ ;
Cuttitta, F .
ENDOCRINOLOGY, 1997, 138 (01) :440-451
[53]   THE NOVEL VASOACTIVE HORMONE, ADRENOMEDULLIN, INHIBITS WATER DRINKING IN THE RAT [J].
MURPHY, TC ;
SAMSON, WK .
ENDOCRINOLOGY, 1995, 136 (06) :2459-2463
[54]  
Nakamura M, 1997, CIRCULATION, V95, P1214
[55]   INCREASED PLASMA-LEVELS OF ADRENOMEDULLIN IN PATIENTS WITH HEART-FAILURE [J].
NISHIKIMI, T ;
SAITO, Y ;
KITAMURA, K ;
ISHIMITSU, T ;
ETO, T ;
KANGAWA, K ;
MATSUO, H ;
OMAE, T ;
MATSUOKA, H .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1995, 26 (06) :1424-1431
[56]   CLINICAL-STUDIES ON THE SITES OF PRODUCTION AND CLEARANCE OF CIRCULATING ADRENOMEDULLIN IN HUMAN-SUBJECTS [J].
NISHIKIMI, T ;
KITAMURA, K ;
SAITO, Y ;
SHIMADA, K ;
ISHIMITSU, T ;
TAKAMIYA, M ;
KANGAWA, K ;
MATSUO, H ;
ETO, T ;
OMAE, T ;
MATSUOKA, H .
HYPERTENSION, 1994, 24 (05) :600-604
[57]   Different secretion patterns of adrenomedullin, brain natriuretic peptide, and atrial natriuretic peptide during exercise in hypertensive and normotensive subjects [J].
Nishikimi, T ;
Morimoto, A ;
Ishikawa, K ;
Saito, Y ;
Kangawa, K ;
Matsuo, H ;
Kitamura, K ;
Takishita, S ;
Matsuoka, H .
CLINICAL AND EXPERIMENTAL HYPERTENSION, 1997, 19 (04) :503-518
[58]   The relaxant effect of adrenomedullin on particular smooth muscles despite a general expression of its mRNA in smooth muscle, endothelial and epithelial cells [J].
Nishimura, J ;
Seguchi, H ;
Sakihara, C ;
Kureishi, Y ;
Yoshimura, H ;
Kobayashi, S ;
Kanaide, H .
BRITISH JOURNAL OF PHARMACOLOGY, 1997, 120 (02) :193-200
[59]   Increased plasma concentrations of adrenomedullin correlate with relaxation of vascular tone in patients with septic shock [J].
Nishio, K ;
Akai, Y ;
Murao, Y ;
Doi, N ;
Ueda, S ;
Tabuse, H ;
Miyamoto, S ;
Dohl, K ;
Minamino, N ;
Shoji, H ;
Kitamura, K ;
Kangawa, K ;
Matsuo, H .
CRITICAL CARE MEDICINE, 1997, 25 (06) :953-957
[60]  
Nossaman BD, 1998, ADRENOMEDULLIN, P143